Protonix and Ontak drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Protonix (pantoprazole sodium) and Ontak (denileukin diftitox). Common drug interactions include acute graft versus host disease in intestine among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Protonix and Ontak. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Protonix?

Protonix has active ingredients of pantoprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 132,658 Protonix users. Check the latest studies of Protonix.

What is Ontak?

Ontak has active ingredients of denileukin diftitox. eHealthMe is studying from 457 Ontak users. Check the latest studies of Ontak.



On Jul, 09, 2026

18 people who take Protonix and Ontak together, and have interactions are studied.

Protonix and Ontak drug interactions.

What are the common drug interactions of Protonix and Ontak, by gender? *:

female:

  1. Acute graft versus host disease in intestine (acute complication in intestine following an allogeneic tissue/blood transplant)
  2. Neoplasm malignant (cancer tumour)
  3. Pyrexia (fever)
  4. Cerebral haemorrhage (bleeding within the brain)
  5. Diarrhoea
  6. Hypertension (high blood pressure)
  7. Intraventricular haemorrhage (intraventricular bleeding)
  8. Nausea (feeling of having an urge to vomit)
  9. Renal cell carcinoma (a kidney cancer)
  10. Subarachnoid haemorrhage (blood leaks into the space between two membranes that surround the brain)

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Actinic keratosis (skin disease due to sun exposure)
  3. Peripheral t-cell lymphoma unspecified (peripheral t-cell cancer unspecified)
  4. Pyoderma (any skin disease that is pyogenic)
  5. Somnolence (a state of near-sleep, a strong desire for sleep)
  6. Abasia (inability to walk)
  7. Death
  8. Decreased appetite
  9. General physical health deterioration (weak health status)
  10. Lung neoplasm malignant (cancer tumour of lung)

What are the common drug interactions of Protonix and Ontak, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Cerebral haemorrhage (bleeding within the brain)
  2. Hypertension (high blood pressure)
  3. Intraventricular haemorrhage (intraventricular bleeding)
  4. Scotoma (an area of diminished vision within the visual field)
  5. Subarachnoid haemorrhage (blood leaks into the space between two membranes that surround the brain)
  6. Vision blurred

40-49:

  1. Actinic keratosis (skin disease due to sun exposure)
  2. Acute respiratory failure
  3. Asthenia (weakness)
  4. Blood albumin decreased
  5. Blood calcium decreased
  6. Confusional state
  7. Dyspnoea (difficult or laboured respiration)
  8. Erythema (redness of the skin)
  9. Oedema peripheral (superficial swelling)
  10. Pain

50-59:

n/a

60+:

  1. Leukopenia (less number of white blood cells in blood)
  2. Neoplasm malignant (cancer tumour)
  3. Neutropenia (an abnormally low number of neutrophils)
  4. Thrombocytopenia (decrease of platelets in blood)
  5. Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)
  6. Pyrexia (fever)
  7. Dyspnoea (difficult or laboured respiration)
  8. Fatigue (feeling of tiredness)
  9. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  10. Renal cell carcinoma (a kidney cancer)

What are the existing conditions these people have? *

  1. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 5 people, 27.78%
  2. Constipation: 4 people, 22.22%
  3. High Blood Pressure: 4 people, 22.22%
  4. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 3 people, 16.67%
  5. T-Cell Lymphoma (a blood cell cancer): 2 people, 11.11%
  6. Pain: 2 people, 11.11%
  7. Ovarian Cancer Metastatic (cancer of ovary spreads to other organ or parts): 2 people, 11.11%
  8. Non-Small Cell Lung Cancer Stage Iv: 2 people, 11.11%
  9. Nausea And Vomiting: 2 people, 11.11%
  10. Nausea (feeling of having an urge to vomit): 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Protonix and Ontak?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Protonix and Ontak:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Protonix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ontak:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Protonix and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ontak and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on pantoprazole sodium and denileukin diftitox (the active ingredients of Protonix and Ontak, respectively), and Protonix and Ontak (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: